Muestra la distribución de disciplinas para esta publicación.
Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.
Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Consultas o comentarios: productividad@anid.cl
Cost-benefit of incorporating detection of circulating prostate cells in a screening program for prostate cancer.
| Indexado |
|
||
| DOI | |||
| Año | 2013 | ||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Abstract
CONCLUSIONS: The use of primary CPC detection as a complementary test in men with a serum PSA >4.0ng/ml to indicate prostate biopsy is a specific, cost effective test, eliminating approximately 70% of prostate biopsies. This results in a significant health care saving both in direct and indirect costs, in the costs of complications. Implementation costs were minimal as equipment and reagents are part of the routine clinical laboratory The method deserves further investigation to confirm the results.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | MURRAY-MCCLURE, NIGEL PETER | Hombre |
Hospital de Carabineros - Chile
Universidad Mayor - Chile Inst Biooncol - Chile |
| 2 | REYES-MORAGA, EDUARDO FELIPE | Hombre |
Hospital de Carabineros - Chile
Universidad Diego Portales - Chile |
| 3 | ORELLANA-SALINAS, NELSON RODRIGO | Mujer |
Hospital de Carabineros - Chile
|
| 4 | TAPIA-CAMPILLAY, PABLO | Hombre |
Pontificia Universidad Católica de Chile - Chile
|
